Payer value engagement strategy and value pack

From the earliest Phase 1 and 2 planning right through health technology assessment (HTA) and post-launch commercialization, you need to create a compelling, evidence-based value proposition that brings the value of your asset alive to payer decision makers in a meaningful way and maximizes good-quality patient access.


You will receive a full payer value engagement service; this includes early aspirational value proposition development, early and late global value dossiers, objection handlers, HTA submissions, including our innovative PRMA Healthcheck® digital application, advanced budgetary notifications, patient dossiers, and payer negotiation playbooks.


Throughout the product lifecycle, our approach to payer value engagement consistently gives you a compelling, differentiated narrative grounded in evidence. This is based on a deep understanding of current and evolving payer drivers to make the value of your asset stand out from the crowd.


Our consulting solutions include:

  • Payer value proposition development and testing
  • Payer objection handlers
  • Payer negotiation guides and playbooks
  • Pre-approval information exchange/advanced budgetary notifications (US)
  • ICER strategy (US)
  • Global value dossiers
  • AMCP dossiers (US)
  • HTA submissions and submission support
  • Patient dossiers


These services are provided by Avalere, PAI, PRMA Consulting, and Skysis – part of Fishawack Health.

Request a call

The work was awesome and your team have been fantastic from start to finish – responsive and prompt to take action. I will definitely choose to work with your consultancy again.

Associate Director Global Market Access and Pricing, top-5 pharmaceutical company.

You have a vision; we are the consulting partner that will get you there.
We would be delighted to have a confidential conversation about your market access needs.